Molecular Dynamics: New Frontier in Personalized Medicine.
暂无分享,去创建一个
[1] G. C,et al. Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors , 2014, Scientific Reports.
[2] Shichen Wang,et al. Molecular Dynamics Analysis Reveals Structural Insights into Mechanism of Nicotine N-Demethylation Catalyzed by Tobacco Cytochrome P450 Mono-Oxygenase , 2011, PloS one.
[3] B. Rannala,et al. The Functional Significance of Common Polymorphisms in Zinc Finger Transcription Factors , 2014, G3: Genes, Genomes, Genetics.
[4] Campbell McInnes,et al. Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.
[5] Vijay S Pande,et al. Protein folding under confinement: A role for solvent , 2007, Proceedings of the National Academy of Sciences.
[6] Alexander D. MacKerell,et al. Combined ab initio/empirical approach for optimization of Lennard–Jones parameters , 1998 .
[7] Michal Otyepka,et al. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations. , 2011, Biochimica et biophysica acta.
[8] R. Marais,et al. A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Dimitrios Vlachakis,et al. Gromita: A Fully Integrated Graphical User Interface to Gromacs 4 , 2009, Bioinformatics and biology insights.
[10] J. Park,et al. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. , 2010, Lung cancer.
[11] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[12] Molecular Dynamics Simulation Study for Ionic Strength Dependence of RNA-host factor Interaction in Staphylococcus aureus Hfq , 2010 .
[13] Andersen,et al. Molecular-dynamics simulation of amorphous germanium. , 1986, Physical review. B, Condensed matter.
[14] Yubao Cui,et al. Molecular Dynamics Simulation and Bioinformatics Study on Yeast Aquaporin Aqy1 from Pichia pastoris , 2012, International journal of biological sciences.
[15] Dmitrij Frishman,et al. STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..
[16] Jacob D. Durrant,et al. Molecular dynamics simulations and drug discovery , 2011, BMC Biology.
[17] David E. Shaw,et al. The future of molecular dynamics simulations in drug discovery , 2011, Journal of Computer-Aided Molecular Design.
[18] Wei Zhang,et al. A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.
[19] J. R. Grigera,et al. The behavior of the hydrophobic effect under pressure and protein denaturation. , 2010, Biophysical journal.
[20] Robert V. Swift,et al. Rational Prediction with Molecular Dynamics for Hit Identification , 2012, Current topics in medicinal chemistry.
[21] J. Maxa,et al. Drug Interactions Due to Cytochrome P450 , 2000, Proceedings.
[22] B. Maigret,et al. New Binding Site Conformations of the Dengue Virus NS3 Protease Accessed by Molecular Dynamics Simulation , 2013, PloS one.
[23] M. Gerstein,et al. Conformational changes associated with protein-protein interactions. , 2004, Current opinion in structural biology.
[24] D. Frenkel,et al. Molecular dynamics simulations. , 2002, Current opinion in structural biology.
[25] Zeming Chen,et al. Specifically targeted delivery of protein to phagocytic macrophages , 2015, International journal of nanomedicine.
[26] Stephen Neidle,et al. Molecular Dynamics Studies of the STAT3 Homodimer: DNA Complex: Relationships between STAT3 Mutations and Protein-DNA Recognition , 2012, J. Chem. Inf. Model..
[27] D. Case,et al. Constant pH molecular dynamics in generalized Born implicit solvent , 2004, J. Comput. Chem..
[28] D. Case,et al. Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.
[29] T. Halgren. MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular‐interaction energies and geometries , 1999, Journal of computational chemistry.
[30] Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity , 2011, EPMA Journal.
[31] Ioan Andricioaei,et al. On the calculation of entropy from covariance matrices of the atomic fluctuations , 2001 .
[32] J. Mccammon,et al. HIV‐1 protease molecular dynamics of a wild‐type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs , 2004, Protein science : a publication of the Protein Society.
[33] T. Hankemeier,et al. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.
[34] Benjamin G. Levine,et al. Ab initio molecular dynamics of excited-state intramolecular proton transfer using multireference perturbation theory. , 2007, The journal of physical chemistry. A.
[35] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[36] Dhavendra Kumar,et al. Genomic medicine: a new frontier of medicine in the twenty first century , 2007, Genomic Medicine.
[37] I. Koh,et al. Drug to SNP: A Pharmacogenomics Database for Linking Drug Response to SNPs , 2001 .
[38] Philip E. Bourne,et al. Con-Struct Map: a comparative contact map analysis tool , 2007, Bioinform..
[39] R. Hilgenfeld,et al. Utility of homology models in the drug discovery process , 2004, Drug Discovery Today.
[40] David S Wishart,et al. A simple method to predict protein flexibility using secondary chemical shifts. , 2005, Journal of the American Chemical Society.
[41] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[42] Wei Zhang,et al. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression , 2010, The Prostate.
[43] M. Levitt,et al. Potential energy function and parameters for simulations of the molecular dynamics of proteins and nucleic acids in solution , 1995 .
[44] R. Brüschweiler,et al. Quantitative molecular ensemble interpretation of NMR dipolar couplings without restraints. , 2007, Journal of the American Chemical Society.
[45] A. Gronenborn,et al. Determination of three‐dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms Circumventing problems associated with folding , 1988, FEBS letters.
[46] Mark Kroese,et al. 'Personalized medicine': what's in a name? , 2014, Personalized medicine.
[47] Peng Yang,et al. Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs , 2014, J. Chem. Inf. Model..
[48] Michal Otyepka,et al. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. , 2008, The journal of physical chemistry. B.
[49] Luonan Chen,et al. Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach , 2013, Human Genomics.
[50] C. Brooks,et al. Recent advances in the development and application of implicit solvent models in biomolecule simulations. , 2004, Current opinion in structural biology.
[51] M. Oscarson. Pharmacogenetics of Drug Metabolising Enzymes: Importance for Personalised Medicine , 2003, Clinical chemistry and laboratory medicine.
[52] Gert Vriend,et al. Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.
[53] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[54] W. L. Jorgensen,et al. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.
[55] Amedeo Caflisch,et al. The Free Energy Landscape of Small Molecule Unbinding , 2011, PLoS Comput. Biol..
[56] Emmanuel Barillot,et al. Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial , 2014, Front. Genet..
[57] Andrew D. Johnson,et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability , 2005, Pharmacogenetics and genomics.
[58] Laxmikant V. Kale,et al. NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .
[59] V. Acharya,et al. Hansa: An automated method for discriminating disease and neutral human nsSNPs , 2012, Human mutation.
[60] Torsten Schwede,et al. Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.
[61] Tariq Ahmad Masoodi,et al. In silico analysis of Single Nucleotide Polymorphisms (SNPs) in human BRAF gene. , 2012, Gene.
[62] Alexander D. MacKerell,et al. Comparison of protein force fields for molecular dynamics simulations. , 2008, Methods in molecular biology.
[63] Paul D Lyne,et al. Structure-based virtual screening: an overview. , 2002, Drug discovery today.
[64] C. Swanton,et al. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. , 2012, Biochemical pharmacology.
[65] A. Lang,et al. Response to clozapine in a clinically identifiable subtype of schizophrenia. , 2015, The British journal of psychiatry : the journal of mental science.
[66] Marialva Sinigaglia,et al. New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir , 2014, PloS one.
[67] M. Orozco,et al. Cooperativity in drug-DNA recognition: a molecular dynamics study. , 2001, Journal of the American Chemical Society.
[68] C. George Priya Doss,et al. Computational Refinement of Functional Single Nucleotide Polymorphisms Associated with ATM Gene , 2012, PloS one.
[69] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[70] M. Ducreux,et al. Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. , 2013, Cancer treatment reviews.
[71] A. Mark,et al. Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: A molecular dynamics study , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[72] A. Caflisch,et al. Molecular dynamics in drug design. , 2015, European journal of medicinal chemistry.
[73] Wei Zhang,et al. In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy , 2014, International journal of molecular sciences.
[74] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[75] Zahra Karimi,et al. VMD DisRg: New User-Friendly Implement for calculation distance and radius of gyration in VMD program , 2012, Bioinformation.
[76] Euan A Ashley,et al. Personalized medicine: hope or hype? , 2012, European heart journal.
[77] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[78] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[79] J. Ponder,et al. Force fields for protein simulations. , 2003, Advances in protein chemistry.
[80] L. Lewis. Personalized drug therapy; the genome, the chip and the physician. , 2005, British journal of clinical pharmacology.
[81] G. Klebe,et al. Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. , 2002, Angewandte Chemie.
[82] D. Tobias,et al. Electrostatic interactions and hydrogen bond dynamics in chloride pumping by halorhodopsin. , 2014, Biochimica et biophysica acta.
[83] D Peter Tieleman,et al. Molecular dynamics simulation of spontaneous membrane fusion during a cubic-hexagonal phase transition. , 2002, Biophysical journal.
[84] Maxim Dolgushev,et al. Dynamics of semiflexible scale-free polymer networks. , 2014, The Journal of chemical physics.
[85] Predrag Radivojac,et al. Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..
[86] R. Altman,et al. WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation , 2013, BMC Genomics.
[87] R. Kream,et al. Personalized- and One- Medicine: Bioinformatics Foundation in Health and its Economic Feasibility , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[88] Pramod Katara,et al. Role of bioinformatics and pharmacogenomics in drug discovery and development process , 2013, Network Modeling Analysis in Health Informatics and Bioinformatics.
[89] C. George Priya Doss,et al. A New Insight into Structural and Functional Impact of Single-Nucleotide Polymorphisms in PTEN Gene , 2013, Cell Biochemistry and Biophysics.
[90] R. Gargallo,et al. Effect of the reaction field electrostatic term on the molecular dynamics simulation of the activation domain of procarboxypeptidase B. , 2000, Protein engineering.
[91] Cheng-I Weng,et al. Three-dimensional molecular dynamics analysis of processing using a pin tool on the atomic scale , 2000 .
[92] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[93] Charlotte M. Deane,et al. Gro2mat: A package to efficiently read gromacs output in MATLAB , 2014, J. Comput. Chem..
[94] Yang Zhang,et al. I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.
[95] Paul Sharratt,et al. Molecular dynamics methodology for the study of the solvent effects on a concentrated Diels-Alder reaction and the separation of the post-reaction mixture , 1998 .
[96] A. Kolesnikov,et al. Coarse-grained model of glycosaminoglycans in aqueous salt solutions. A field-theoretical approach. , 2014, The journal of physical chemistry. B.
[97] B. Shastry,et al. Pharmacogenetics and the concept of individualized medicine , 2006, The Pharmacogenomics Journal.
[98] R B Altman,et al. The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response , 2007, Clinical pharmacology and therapeutics.
[99] Pradeep Kota. GUIMACS - A Java Based Front End for GROMACS , 2007, Silico Biol..
[100] M. Sansom,et al. How Does a Voltage Sensor Interact with a Lipid Bilayer? Simulations of a Potassium Channel Domain , 2007, Structure.
[101] C. George Priya Doss,et al. Computational Methods to Work as First-Pass Filter in Deleterious SNP Analysis of Alkaptonuria , 2012, TheScientificWorldJournal.
[102] Adrian H Elcock,et al. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. , 2006, Journal of molecular biology.
[103] Xiaowei Yang,et al. Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine , 2014, PLoS Comput. Biol..
[104] Andrew D. Johnson,et al. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. , 2005, Pharmacology & therapeutics.
[105] E. Vauthey,et al. Molecular dynamics simulations of liquid phase interfaces: understanding the structure of the glycerol/water-dodecane system. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[106] U. Singh,et al. A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .
[107] Emil Alexov,et al. Advances in Human Biology: Combining Genetics and Molecular Biophysics to Pave the Way for Personalized Diagnostics and Medicine , 2014 .
[108] Jahan B. Ghasemi,et al. Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin , 2014, Journal of Molecular Modeling.
[109] César Augusto F. de Oliveira,et al. Coupling Constant pH Molecular Dynamics with Accelerated Molecular Dynamics , 2010, Journal of chemical theory and computation.
[110] P. Ruitenbeek,et al. Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory , 2010, British journal of pharmacology.
[111] Robin D Couch,et al. Personalized medicine: changing the paradigm of drug development. , 2012, Methods in molecular biology.
[112] A. Y. Lu,et al. Pharmacogenetics, Pharmacogenomics, and Individualized Medicine , 2011, Pharmacological Reviews.
[113] Munir Pirmohamed,et al. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. , 2014, Annual review of genomics and human genetics.
[114] C. Doss,et al. Investigating the Structural Impacts of I64T and P311S Mutations in APE1-DNA Complex: A Molecular Dynamics Approach , 2012, PloS one.
[115] Toshikazu Ebisuzaki,et al. A smooth‐particle mesh Ewald method for DL_POLY molecular dynamics simulation package on the Fujitsu VPP700 , 2000 .
[116] O. V. Galzitskaya,et al. Radius of gyration as an indicator of protein structure compactness , 2008, Molecular Biology.
[117] R. Iida,et al. Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity , 2012, Electrophoresis.
[118] S. Peng,et al. Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population , 2010, Digestive Diseases and Sciences.
[119] M. Steinbach,et al. High-Order SNP Combinations Associated with Complex Diseases: Efficient Discovery, Statistical Power and Functional Interactions , 2012, PloS one.
[120] Hugh S Markus,et al. Personalized medicine: risk prediction, targeted therapies and mobile health technology , 2014, BMC Medicine.
[121] Markus Christen,et al. The GROMOS software for biomolecular simulation: GROMOS05 , 2005, J. Comput. Chem..
[122] Yuxiang Yan,et al. Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health , 2014, EPMA Journal.
[123] Bert L. de Groot,et al. Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations , 2010, PLoS Comput. Biol..
[124] J. Åqvist,et al. Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.
[125] Paolo Tosco,et al. Bringing the MMFF force field to the RDKit: implementation and validation , 2014, Journal of Cheminformatics.
[126] W E Moerner,et al. Principal-components analysis of shape fluctuations of single DNA molecules , 2007, Proceedings of the National Academy of Sciences.
[127] David P Lane,et al. Molecular simulations of protein dynamics: new windows on mechanisms in biology , 2008, EMBO reports.
[128] A. V. Popov,et al. GUI-BioPASED: A program for molecular dynamics simulations of biopolymers with a graphical user interface , 2010, Molecular Biology.
[129] M. Tashiro,et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. , 2002, Life sciences.
[130] Thomas Simonson,et al. Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases* , 2010, The Journal of Biological Chemistry.
[131] Seth I. Berger,et al. Role of systems pharmacology in understanding drug adverse events , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[132] S. H. Chen,et al. Neutron structure factors of in-vivo deuterated amorphous protein C-phycocyanin. , 1993, Biophysical journal.
[133] J Andrew McCammon,et al. HBonanza: a computer algorithm for molecular-dynamics-trajectory hydrogen-bond analysis. , 2011, Journal of molecular graphics & modelling.
[134] A. Laaksonen,et al. Molecular dynamics simulation and NMR study of water-acetonitrile mixtures , 1991 .
[135] M Vendruscolo,et al. Recovery of protein structure from contact maps. , 1997, Folding & design.
[136] Jaroslav Bendl,et al. PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations , 2014, PLoS Comput. Biol..
[137] Luonan Chen,et al. Integrating In Silico Prediction Methods, Molecular Docking, and Molecular Dynamics Simulation to Predict the Impact of ALK Missense Mutations in Structural Perspective , 2014, BioMed research international.
[138] Aleksey A. Porollo,et al. POLYVIEW-MM: web-based platform for animation and analysis of molecular simulations , 2010, Nucleic Acids Res..
[139] Lin Wang,et al. Analyzing Effects of Naturally Occurring Missense Mutations , 2012, Comput. Math. Methods Medicine.
[140] R. Friesner,et al. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .
[141] Andrea Amadei,et al. Molecular dynamics simulation of protein folding by essential dynamics sampling: folding landscape of horse heart cytochrome c. , 2003, Biophysical journal.
[142] N. Subbarao,et al. In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2 , 2015, PloS one.
[143] T. Darden,et al. Molecular dynamics simulations of biomolecules: long-range electrostatic effects. , 1999, Annual review of biophysics and biomolecular structure.
[144] Yury N. Vorobjev,et al. MDTRA: A molecular dynamics trajectory analyzer with a graphical user interface , 2013, J. Comput. Chem..
[145] Holger Gohlke,et al. NMSim Web Server: integrated approach for normal mode-based geometric simulations of biologically relevant conformational transitions in proteins , 2012, Nucleic Acids Res..
[146] Peter A. Kollman,et al. AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions , 1981 .
[147] I. Adzhubei,et al. Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.
[148] Bin Zhou,et al. Common genetic polymorphisms in pre‐microRNAs and risk of cervical squamous cell carcinoma , 2011, Molecular carcinogenesis.
[149] U. Meyer. Pharmacogenetics and adverse drug reactions , 2000, The Lancet.
[150] W. Gmeiner,et al. Molecular dynamics simulation of the human U2B" protein complex with U2 snRNA hairpin IV in aqueous solution. , 2001, Biophysical journal.
[151] Makoto Taiji,et al. High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations , 2009, PLoS Comput. Biol..
[152] Pavel Hobza,et al. Molecular dynamics simulations and thermodynamics analysis of DNA-drug complexes. Minor groove binding between 4',6-diamidino-2-phenylindole and DNA duplexes in solution. , 2003, Journal of the American Chemical Society.
[153] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[154] Supot Hannongbua,et al. Structure, Dynamics and Solvation of HIV-1 Protease/Saquinavir Complex in Aqueous Solution and Their Contributions to Drug Resistance: Molecular Dynamic Simulations , 2005, J. Chem. Inf. Model..
[155] G. Ginsburg,et al. Personalized medicine: revolutionizing drug discovery and patient care. , 2001, Trends in biotechnology.
[156] E. Copson,et al. Clinical proteomics and breast cancer. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[157] Jin Qin,et al. Molecular Dynamics Simulation, Free Energy Calculation and Structure-Based 3D-QSAR Studies of B-RAF Kinase Inhibitors , 2011, J. Chem. Inf. Model..
[158] Yuichi Sugiyama,et al. Impact of Drug Transporter Studies on Drug Discovery and Development , 2003, Pharmacological Reviews.
[159] C. Flück,et al. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. , 2010, Biochemical and biophysical research communications.
[160] Helmut Grubmüller,et al. Keep It Flexible: Driving Macromolecular Rotary Motions in Atomistic Simulations with GROMACS , 2011, Journal of chemical theory and computation.
[161] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[162] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[163] M. Gillard,et al. Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). , 2002, Molecular pharmacology.
[164] Rajendra Kumar,et al. g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..
[165] Donghui Li,et al. Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity , 2009, Clinical Cancer Research.
[166] Burkhard Rost,et al. DSSPcont: continuous secondary structure assignments for proteins , 2003, Nucleic Acids Res..
[167] Guohui Li,et al. Advancement of polarizable force field and its use for molecular modeling and design. , 2015, Advances in experimental medicine and biology.
[168] Alan L Harvey,et al. Natural products in drug discovery. , 2008, Drug discovery today.
[169] Yang Song,et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery , 2011, Nucleic Acids Res..
[170] J. Berg,et al. Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.
[171] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[172] C. George Priya Doss,et al. Computational approaches and resources in single amino acid substitutions analysis toward clinical research. , 2014, Advances in protein chemistry and structural biology.
[173] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[174] Wilfred F. van Gunsteren,et al. An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase , 2001, J. Comput. Chem..
[175] T. Halgren. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions , 1996 .
[176] N. Zhang,et al. Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2α as determined by molecular dynamics , 2010, Journal of molecular modeling.
[177] Vittorio Scarano,et al. COCOMAPS: a web application to analyze and visualize contacts at the interface of biomolecular complexes , 2011, Bioinform..
[178] Sven Frokjaer,et al. Predicting Drug Absorption from Molecular Surface Properties Based on Molecular Dynamics Simulations , 1998, Pharmaceutical Research.
[179] K. Schulten,et al. Single-Molecule Experiments in Vitro and in Silico , 2007, Science.
[180] A. Sali,et al. Modeller: generation and refinement of homology-based protein structure models. , 2003, Methods in enzymology.
[181] S. Derks,et al. Personalized cancer medicine: next steps in the genomic era , 2015, Cellular Oncology.
[182] V. Daggett,et al. Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. , 2002, Journal of molecular biology.
[183] Sunil K. Panigrahi. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study , 2008, Amino Acids.
[184] R. Purohit,et al. A novel computational and structural analysis of nsSNPs in CFTR gene , 2008, Genomic Medicine.
[185] Vitaly A. Kuzkin,et al. On angular momentum balance for particle systems with periodic boundary conditions , 2013, 1312.7008.
[186] R. Iyengar,et al. Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. , 2012, Annual review of pharmacology and toxicology.
[187] Vittorio Scarano,et al. CONSRANK: a server for the analysis, comparison and ranking of docking models based on inter-residue contacts , 2015, Bioinform..
[188] K. Winey,et al. Polymer conformations in polymer nanocomposites containing spherical nanoparticles. , 2015, Soft matter.
[189] T. Lybrand. Ligand-protein docking and rational drug design. , 1995, Current Opinion in Structural Biology.
[190] Dimitrios H Roukos,et al. Individual genomes and personalized medicine: life diversity and complexity. , 2010, Personalized medicine.
[191] Emad Tajkhorshid,et al. Visualizing Functional Motions of Membrane Transporters with Molecular Dynamics Simulations , 2013, Biochemistry.
[192] Chris Oostenbrink,et al. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..
[193] J. Smith,et al. Derivation of a molecular mechanics force field for cholesterol , 2004 .
[194] Indra Neil Sarkar,et al. Bioinformatics opportunities for identification and study of medicinal plants , 2013, Briefings Bioinform..
[195] Ivet Bahar,et al. Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics , 2009, Bioinform..
[196] Sabine C. Mueller,et al. BALL-SNP: combining genetic and structural information to identify candidate non-synonymous single nucleotide polymorphisms , 2015, Genome Medicine.
[197] C. George Priya Doss,et al. Deciphering the impact of somatic mutations in exon 20 and exon 9 of PIK3CA gene in breast tumors among Indian women through molecular dynamics approach , 2016, Journal of biomolecular structure & dynamics.
[198] V Maojo,et al. Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research. , 2013, Computational science & discovery.
[199] Z. Abduljaleel,et al. In Silico Analysis of Single Nucleotide Polymorphism (SNPs) in Human β-Globin Gene , 2011, PloS one.
[200] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[201] Stewart A. Adcock,et al. Molecular dynamics: survey of methods for simulating the activity of proteins. , 2006, Chemical reviews.
[202] S. D. de Alencar,et al. A Comprehensive In Silico Analysis of the Functional and Structural Impact of SNPs in the IGF1R Gene , 2010, Journal of biomedicine & biotechnology.